找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Management of Advanced Prostate Cancer; Choung Soo Kim Book 2018 Springer Nature Singapore Pte Ltd. 2018 Prostate Cancer.radiotherapy.chem

[复制链接]
查看: 7891|回复: 59
发表于 2025-3-21 17:50:08 | 显示全部楼层 |阅读模式
书目名称Management of Advanced Prostate Cancer
编辑Choung Soo Kim
视频video
概述Summarizes the state of the art in the management of locally advanced and metastatic prostate cancer.Evaluates the role of abiraterone and enzalutamide, docetaxel-based chemotherapy, and novel agents.
图书封面Titlebook: Management of Advanced Prostate Cancer;  Choung Soo Kim Book 2018 Springer Nature Singapore Pte Ltd. 2018 Prostate Cancer.radiotherapy.chem
描述This textbook summarizes the state of the art in the management of locally advanced and metastatic prostate cancer with the aim of providing the knowledge required for optimal treatment decision making in individual cases. Readers will find comprehensive coverage of the latest developments in surgery, radiotherapy, androgen deprivation therapy (ADT), chemotherapy, and immunotherapy. The role of the hormonal therapies abiraterone and enzalutamide and docetaxel-based chemotherapy in castration-resistant prostate cancer and hormone-sensitive metastatic disease is carefully evaluated. Among the other therapies discussed are LHRH agonists and antagonists, cabazitaxel, radium-223, and various novel agents still under clinical trials. The section on surgical approaches addresses, among other topics, the use of robot-assisted radical prostatectomy, pelvic lymphadenectomy, and the benefits of adjuvant and neoadjuvant therapy. The current role of external beam radiotherapy, alone or in combination with ADT and brachytherapy, for locally advanced disease is reviewed. .Management of Advanced Prostate Cancer .will be a valuable resource for practitioners at all levels of expertise.
出版日期Book 2018
关键词Prostate Cancer; radiotherapy; chemotherapy; immunotherapy; cancer management; metastatic prostate cancer
版次1
doihttps://doi.org/10.1007/978-981-10-6943-7
isbn_ebook978-981-10-6943-7
copyrightSpringer Nature Singapore Pte Ltd. 2018
The information of publication is updating

书目名称Management of Advanced Prostate Cancer影响因子(影响力)




书目名称Management of Advanced Prostate Cancer影响因子(影响力)学科排名




书目名称Management of Advanced Prostate Cancer网络公开度




书目名称Management of Advanced Prostate Cancer网络公开度学科排名




书目名称Management of Advanced Prostate Cancer被引频次




书目名称Management of Advanced Prostate Cancer被引频次学科排名




书目名称Management of Advanced Prostate Cancer年度引用




书目名称Management of Advanced Prostate Cancer年度引用学科排名




书目名称Management of Advanced Prostate Cancer读者反馈




书目名称Management of Advanced Prostate Cancer读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

1票 100.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:19:44 | 显示全部楼层
Springer Nature Singapore Pte Ltd. 2018
发表于 2025-3-22 03:42:16 | 显示全部楼层
发表于 2025-3-22 06:21:40 | 显示全部楼层
发表于 2025-3-22 10:15:28 | 显示全部楼层
Identifying the Best Candidate for Radical Prostatectomy in High-Risk Prostate Cancer. However, the surgery for localized low-risk prostate cancer may not be the standard anymore due to the concern of overtreatment recently. On the other hand, regarding the treatment of high-risk or locally advanced prostate cancer, the role of surgery started to extend their territory.
发表于 2025-3-22 14:17:47 | 显示全部楼层
发表于 2025-3-22 18:01:13 | 显示全部楼层
发表于 2025-3-22 21:48:08 | 显示全部楼层
Radiotherapy for Prostate Cancer Patients with Pelvic Lymph Node MetastasisThe prostate cancer (PCA) disseminates by the lymphatics, the perineural spaces, and the venous routes through the Santorini’s venous plexus. The lymphatic dissemination includes external iliac nodes, hypogastric nodes, and lateral and subaortic sacral nodes [1].
发表于 2025-3-23 02:53:28 | 显示全部楼层
Natural History of High-Risk Prostate Canceroreover, in developed countries, prostate cancer is ranked first among male cancer. In the view of mortality, prostate cancer is the fifth most common cause of death among male cancer, and approximately 307,500 patients died from prostate cancer worldwidely in 2012. Given the high incidence of prost
发表于 2025-3-23 06:38:44 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-5 20:36
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表